Loading…
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
14 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BRIVARACETAM10mg/ml · Solution | Brivaracetam | United States | Marketed | 2026 |
| DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE10mg; 5mg base · Tablet | Dapagliflozin, Saxagliptin | United States | Marketed | 2026 |
| DEXRAZOXANE HYDROCHLORIDE250mg base/vial | 500mg base/vial · Injectable | Dexrazoxane | United States | Marketed | 2004 |
| IRBESARTAN150mg | 300mg | 75mg · Tablet | Irbesartan | United States | Marketed | 2012 |
| IVABRADINE HYDROCHLORIDE5mg base | 7.5mg base · Tablet | Ivabradine | United States | Marketed | 2021 |
| LURASIDONE HYDROCHLORIDE120mg | 20mg | 40mg | 60mg | 80mg · Tablet | Lurasidone | United States | Marketed | 2017 |
| OLUMIANT1mg | 2mg | 4mg · Tablet | Baricitinib | United States | Marketed | 2018 |
| PERAMPANEL0.5mg/ml · Suspension | Perampanel | United States | Marketed | 2025 |
| PERAMPANEL10mg | 12mg | 2mg | 4mg | 6mg | 8mg · Tablet | Perampanel | United States | Marketed | 2021 |
| PIMAVANSERIN34mg base · Capsule | Pimavanserin | United States | Not marketed | 2024 |
| THIOTEPA100mg/vial | 15mg/vial · Powder | Thiotepa | United States | Marketed | 2020 |
| TOREMIFENE CITRATE60mg base · Tablet | Toremifene | United States | Marketed | 2018 |
| AFATINIB20mg | 30mg | 40mg · Tablet | Afatinib | United States | tentative | 2026 |
| CARFILZOMIB10mg | 30mg | 60mg · Injectable | Carfilzomib | United States | tentative | 2023 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 14 | 12 | 2 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Keep Msn’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callOther companies in the same group.